Global Vasuclar Stents Market (Coronary Stents, Neurovascular Stents & Peripheral Vascular Stents) Market Outlook 2024

Abstract
Vascular stents are tubes inserted into blood vessels anywhere in the body for management of atherosclerosis. These stents are mainly used for cardiovascular stenosis. It leads to significant reduction in occurrence of acute vascular occlusion and restenosis. Vascular stents are classified as coronary artery stents, peripheral stents, and neurovascular stents. Amongst all the aforementioned vascular stents, coronary artery stents is seen to have revolutionized the practice of interventional cardiology. Demand for vascular stents has been rising on an increasing spree due to higher prevalence of diseases affecting heart and blood vessels of elderly and middle-aged population.

Growth of global vascular stents market is primarily attributed to prevalence of vascular diseases, increasing geriatric population, preference for minimally invasive procedure and favorable reimbursement policies. However, some of the factors restraining growth of the industry are stringent regulatory norms, high cost of devices, slow adoption rate and post-operative complications.

The report “Global Vascular Stents Market (Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents)-Market Outlook 2024” provides information on the current scenario, market outlook of the global vascular stents market with detailed analysis of market segments such as Coronary Artery Stents, Neurovascular Stents & Peripheral Vascular Stents. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Future forecasts of vascular stents market overall and across various sub-segments has been provided till 2024, for all the geographies. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global vascular stents market includes Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation and Microport Scientific Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global as well as regional vascular stents market.

Content
1. Executive Summary
2. Research Methodology
3. Vascular Stents
3.1 Background
3.2 Overview
3.3 Classification
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Products
4.2.2 Market share by Type
4.2.3 Market Share by Region
5. Market Segmentation
5.1 Coronary Stents
5.1.1 Overview
5.1.2 Market Sizing (Actual & Forecasted)
5.1.3 Market Share by Products
5.1.3.1 Bare Metal Stent
5.1.3.2 Bioresorbable Stent
5.1.3.3 Drug Eluting Stent
5.1.4 Market Share by Region
5.2 Neurovascular Stents
5.2.1 Overview
5.2.2 Market Sizing (Actual & Forecasted)
5.3 Peripheral Vascular Stents
5.3.1 Overview
5.3.2 Market Sizing (Actual & Forecasted)
5.3.3 Market Share by Products
5.3.3.1 Femoral Artery Stent
5.3.3.2 Infrapop Artery Stent
5.3.3.3 Iliac Artery Stent
5.3.5 Market Share by Region
6. Regional Analysis
6.1 North America
6.1.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.1.2 Market Share by Stent Type
6.1.3 The US
6.1.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2 Europe
6.2.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.2.2 Market Share by Stent Type
6.3 Asia Pacific
6.3.1 Vascular Stent Market Sizing (Actual & Forecasted)
6.3.2 Market Share by Products
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Advent of Bioresorbable Vascular Stents
7.1.2 Technological Advancement
7.2 Growth Drivers
7.2.1 Increasing Geriatric Population
7.2.2 Prevalence of Vascular Diseases
7.2.3 Preference for Minimally Invasive Procedures
7.2.4 Favorable Reimbursement Policies
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 Post-Operative Complications
7.3.3 Slow Adoption Rate
7.3.4 High Cost of Devices
8. Competitive Landscape
8.1 Market Share Analysis
9. Company Profiles
9.1 Abbott Laboratories
9.2 Medtronic PLC
9.3 Boston Scientific Corporation
9.4 Microport Scientific Corporation